Document is current
Any future updates will be listed below
-
Authors
de Abreu, Paloma
Cabrera, Sonia
Cordovilla, Darwin
Román, Lourdes
Brunengo, Cristina
Melgarejo, Patricia
Soto, Macarena
Valinotti, Vannia
Amarilla, Angelica
Acevedo, Belem
Pineda, Alexis
Leiva, Evelyn
Pusineri, Paola
Consani, Sandra
Zarza, Mariela
Parodi, Clyde
Morel, Zoilo
Rolón, Roger
Jara, Paola
Aranda, Raquel
Martínez, Laura
Ávila, Gabriela
Martínez, Carmen
Babak, Pedro
Elizaur, Gabriel
Franco, Marco
Delgadillo, Pedro
Romero, Teresa
Valinotti, Vania
Glizt, Romina
Gómez, Sany
Mazzoleni, Julio
Paredes, Ernesto
Borja, Juan Fernando
Vega, Cynthia
Zanotti, Magali
Acosta, Rodrigo
Paats, Astrid
Vázquez, Marcos
Acosta, María Isabel
Coronel, Claudia
Albanese, Miguel
Corbacho, Inés
Palleiro, Daniel
Ramagli, Alicia
Calegari, Margarita
Teijeiro, Raquel
Cordovilla, Darwin Octavio
Haguindeguy, Mariela
Rostan, Sofía
Garino, Pilar
Díaz, Carolina
Fernández, Alejandro
Velázquez, Pamela
Bertola, María
Barteshagi, Gonzalo
Drago, Lucia
Jurado, Rosario
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: data from the BIOBADAGUAY registry
Journal Title: Reumatología Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2025.101798
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2024.09.008
Content Type: article
Copyright: © 2024 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
